Effects of polysaccharide from Physalis alkekengi var. francheti on liver injury and intestinal microflora in type-2 diabetic mice

References

• Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 101:15718–15723.
   PubMed Web of Science ®Google Scholar
• Cani PD, Delzenne NM. 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 15:1546–1558.
   PubMed Web of Science ®Google Scholar
• Cesaroa C, Tiso A, Pretea AD, Cariello R, Tuccillo C, Cotticelli G, Blanco C, Loguercio C. 2011. Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis. 43:431–438.
   PubMedGoogle Scholar
• Domitrovi R. 2011. The molecular basis for the pharmacological activity of anthocyans. Curr Med Chem. 18:4454–4469.
   PubMed Web of Science ®Google Scholar
• Ge Y, Duan YF, Fang GZ, Wang S. 2009. Polysaccharides from fruit calyx of Physalis alkekengi var. francheti: Isolation, purification, structural features and antioxidant activities. Carbohyd Polym. 77:188–193.
   Web of Science ®Google Scholar
• Goetsch KP, Niesler CU. 2016. The extracellular matrix regulates the effect of decorin and transforming growth factor beta-2 (TGF-β2) on myoblast migration. Biochem Bioph Res Co. 479:351–357.
   PubMed Web of Science ®Google Scholar
• Ji L, Yuan YL, Luo LP, Chen Z, Ma XQ, Ma ZJ, Cheng L. 2012. Physalins with anti-inflammatory activity are present in Physalis alkekengi var. francheti and can function as Michael reaction acceptors. Steroids. 77:441–447.
   PubMed Web of Science ®Google Scholar
• Jiang GQ, Liu J, Ren BY, Tang YW, Owusu L, Li M, Zhang J, Liu LK, Li WL. 2016. Anti-tumor effects of osthole on ovarian cancer cells in vitro. J Ethnopharmacol. 193:368–376.
   PubMed Web of Science ®Google Scholar
• Kong Q, He GQ, Jia JL, Zhu QL, Ruan H. 2011. Oral administration of Clostridium butyricum for modulating gastrointestinal microflora in mice. Curr Microbiol. 62:512–517.
   PubMed Web of Science ®Google Scholar
• Lee YH, Kim JH, Kim SR, Jin HY, Rhee EJ, Cho YM, Lee BW. 2017. Lobeglitazone, a novel thiazolidinedione, improves non-alcoholic fatty liver disease in type 2 diabetes: Its efficacy and predictive factors related to responsiveness. J Korean Med Sci. 32:60–69.
   PubMed Web of Science ®Google Scholar
• Li XL, Yang G, Zhang CL, Wu DC, Tang L, Xin Y. 2014. Improvement of intestinal microflora balance by polysaccharide from Physalis alkekengi var. francheti. Mol Med Rep. 9:677–682.
   PubMed Web of Science ®Google Scholar
• Mosca S, Gargiulo P, Balato N, Di Costanzo L, Parente A, Paolillo S, Ayala F, Trimarco B, Crea F, Perrone-Filardi P. 2015. Ischemic cardiovascular involvement in psoriasis: a systematic review. Int J Cardiol. 178:191–199.
   PubMed Web of Science ®Google Scholar
• Muyzer G, Dewaal EC, Uitterlinden AG. 1993. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol. 59:695–700.
   PubMed Web of Science ®Google Scholar
• Ruth EL, Peter JT, Samuel K, Jeffrey IG. 2006. Human gut microbes associated with obesity. Nature. 444:1022–1023.
   PubMed Web of Science ®Google Scholar
• Stappenbeck TS, Hooper LV, Gordon JI. 2002. Developmental regulation of intestinal angiogenesis by indigenous microbes via paneth cells. Proc Natl Acad Sci USA. 99:15451–15455.
   PubMed Web of Science ®Google Scholar
• Serino M, Luche E, Chabo C, Amar J, Burcelin R. 2009. Intestinal microflora and metabolic diseases. Diabetes Metab. 35:262–272.
   PubMed Web of Science ®Google Scholar
• Thu VT, Kim HK, Long LT, Thuy TT, Huy NQ, Kim SH, Kim N, Ko KS, Rhee BD, Han J. 2016. NecroX-5 exerts anti-inflammatory and anti-fibrotic effects via modulation of the TNF-α/Dcn/TGF-β1/Smad2 pathway in hypoxia/reoxygenation-treated rat hearts. Korean J Physiol Pharmacol. 20:305–314.
   PubMed Web of Science ®Google Scholar
• Tong HB, Liang ZY, Wang GY. 2008. Structural characterization and hypoglycemic activity of a polysaccharide isolated from the fruit of Physalis alkekengi L. Carbohyd Polym. 71:316–323.
   Web of Science ®Google Scholar
• Tong HB, Wang RF, Liu XM, Wang GY, Du FG, Zeng XL. 2011. Structural characterization and in vitro inhibitory activities in P-selectin-mediated leukocyte adhesion of polysaccharide fractions isolated from the roots of Physalis alkekengi. Int J Biol Macromol. 49:210–217.
   PubMed Web of Science ®Google Scholar
• Umar A, Ahmed QU, Muhammad BY, Dogarai BBS, Soad SZBM. 2010. Anti-hyperglycemic activity of the leaves of Tetracera scandens Linn. Merr. (Dilleniaceae) in alloxan induced diabetic rats. J Ethnopharmacol. 13:140–145.
   Web of Science ®Google Scholar
• Wan Y, Garner J, Wu N, Phillip L, Han YY, McDaniel K, Annable T, Zhou TH, Francis H, Glaser S, et al. 2016. Role of stem cells during diabetic liver injury. J Cell Mol Med. 20:195–203.
   PubMed Web of Science ®Google Scholar
• Wang CY, Yin YL, Cao XJ, Li XL. 2016. Effects of Maydis stigma polysaccharide on the intestinal microflora in type-2 diabetes. Pharm Biol. 54:3086–3092.
   PubMed Web of Science ®Google Scholar
• Xiao JB, Huo J, Jiang H, Yang F. 2011. Chemical compositions and bioactivities of crude polysaccharides from tea leaves beyond their useful date. Int J Biol Macromol. 49:1143–1151.
   PubMed Web of Science ®Google Scholar
• Yang N, Zhao MM, Zhu BH, Yang B, Chen CH, Cui C, Jiang YM. 2008. Anti-diabetic effects of polysaccharides from Opuntia monacantha cladode in normal and streptozotocin-induced diabetic rats. Innov Food Sci Emerg. 9:570–574.
   Web of Science ®Google Scholar
• Zhao WZ, Yin YG, Yua ZP, Liu JB, Chen F. 2012. Comparison of anti-diabetic effects of polysaccharides from corn silk on normal and hyperglycemia rats. Int J Biol Macromol. 50:1133–1137.
   PubMed Web of Science ®Google Scholar